Thirty-six patients with AL received, in a three-month period, 51 cycles of combined chemotherapy which included, in all of them, cytosine arabinoside (ARA-C); among them, along with myelosuppression, five experienced fever, infectious complications, gastrointestinal tract symptoms and severe myalgias.
infectious complications
ARA-C
gastrointestinal tract symptoms
ARA-C
severe myalgias
cytosine arabinoside
fever
ARA-C
severe myalgias
ARA-C
infectious complications
cytosine arabinoside
gastrointestinal tract symptoms
cytosine arabinoside
fever
cytosine arabinoside